'Obamacare' is constitutional, says US Supreme Court

29 June 2012

In a five to four decision delivered yesterday by Chief Justice John Roberts, the US Supreme Court upheld most of President Barack Obama's signature health care reform act, or the Affordable Care Act dubbed "Obamacare," which has been strongly opposed by Republicans, who have said they would repeal the bill if they gained power.

However, the Court did not uphold the law in its entirety, declaring the expansion of the Medicaid health insurance plan to be unconstitutional because it required states to expand coverage or lose all federal funding of the Medicaid program for the poor, saying the federal government cannot threaten to withhold money from states that do not fully comply.

Pres Obama's Act mandates that, from 2014, all Americans must buy health insurance, or face hundreds of dollars of fines. By compelling young and healthy people in the insurance market, the White House believed it would be able to push down the cost of insurance premiums for all and subsidize coverage for the poorest.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical